Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2000
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066179A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000WO2000066176A2 Agent for gene therapy and for the prevention of metastases, as well as for the gene therapy of tumors
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000WO2000066165A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
11/09/2000WO2000066159A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000WO2000066153A1 RAS ONCOGEN p21 PEPTIDE VACCINES
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066135A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000WO2000066134A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000WO2000066127A1 Novel highly lipophilic camptothecin analogs
11/09/2000WO2000066125A1 Method for treating cancer using camptothecin derivatives and 5-fluorouracil
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066111A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000066103A2 Contraceptive compositions containing cyclic urea and amide derivatives
11/09/2000WO2000066095A2 Use of estrone derivatives as antitumour agents
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000066093A2 Combined preparations comprising morpholine anthracyclines and anticancer agent
11/09/2000WO2000066091A1 Amplification of folate-mediated targeting to tumor cells using polymers
11/09/2000WO2000066090A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000WO2000051968A8 Method for the preparation of a chiral-beta-amino ester
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
11/09/2000WO2000039087A3 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000038710A3 Dual hapten modified tumor cells and tumor polypeptides and methods of treating cancer
11/09/2000WO2000037638A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000037489A3 Fragment of the gylcoprotein cd55/daf for producing highly effective anti-tumour medicaments and method for using the same
11/09/2000WO2000037094A3 Therapeutic applications of flint polypeptides
11/09/2000WO2000034477A3 Neuron-associated proteins
11/09/2000WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
11/09/2000WO2000030668A3 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
11/09/2000WO2000029428A3 5t4 tumour-associated antigen for use in tumour immunotherapy
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000025763A3 Agents containing phenol derivatives having an inhibiting effect on the proliferation of tumour cells
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
11/09/2000WO2000021996A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000021509A3 Methods of treatment
11/09/2000WO2000019989A3 Use of catechol derivatives as proteinase inhibitors
11/09/2000WO1999056769A3 Inhibition of helicobacter pylori proliferation
11/09/2000WO1999047678A9 Interferon alpha plasmids and delivery systems, and methods of making and using the same
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000CA2727692A1 Isoflavone metabolites
11/09/2000CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv
11/09/2000CA2373225A1 Oligonucleotides having a-dna form and b-dna form conformational geometry
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372841A1 Amplification of folate-mediated targeting to tumor cells using polymers
11/09/2000CA2372834A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000CA2372772A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000CA2372768A1 Contraceptive compositions containing cyclic urea and amide derivatives
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2372493A1 Steroid derivatives
11/09/2000CA2372223A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000CA2372220A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000CA2372187A1 Ras oncogen p21 peptide vaccines
11/09/2000CA2371766A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000CA2371758A1 2,1-benzisothiazoline 2,2-dioxides
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371726A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000CA2371651A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000CA2371642A1 Cyclic urea and cyclic amide derivatives
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2371633A1 Thio-oxindole derivatives
11/09/2000CA2371632A1 Cyclocarbamate and cyclic amide derivatives
11/09/2000CA2371629A1 3,3-substituted indoline derivatives
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371421A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/09/2000CA2371273A1 Tetracyclic progesterone receptor modulator compounds and methods
11/09/2000CA2370304A1 Specific antibodies and antibody fragments for tgf.beta.1
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2369371A1 Death domain containing receptor 5
11/09/2000CA2369077A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/09/2000CA2368748A1 X-ray guided drug delivery
11/09/2000CA2366805A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/09/2000CA2365776A1 Method for treating abnormal cell proliferation in the brain
11/09/2000CA2365278A1 Tumour-associated antigen
11/09/2000CA2365212A1 Substituted 3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
11/08/2000EP1049781A1 Human chemokine and its use for detection and treatment of breast disease
11/08/2000EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049775A1 Human btrcp protein
11/08/2000EP1049774A2 Promoter regions of the mouse and human telomerase rna component genes
11/08/2000EP1049772A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049718A1 Monoclonal antibody anti alphav-integrin and its use to inhibit alphavbeta6-integrin attachment to fibronectin
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049710A1 Peptides with beta-1 integrin subunit dependent cell adhesion modulating activity
11/08/2000EP1049708A1 Meth1 and meth2 polynucleotides and polypeptides
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049686A1 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
11/08/2000EP1049677A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
1 ... 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 ... 2211